
    
      The purpose of this study is to evaluate the safety and efficacy of Thelin™ (sitaxsentan
      sodium) as compared to placebo in the treatment of patients with PAH. A cohort of patients
      will be randomized to usual treatment with Tracleer® (bosentan) for observational comparisons
      of safety and efficacy.
    
  